Liver Failure Clinical Trials

A listing of Liver Failure medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294-0111

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Arizona

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Tucson Arizona 85724

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

California

Coronado California 92118

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

La Jolla California 92037

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Loma Linda California 92324

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Los Angeles California 90048

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

View More ▼

Rialto California 92377

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

San Francisco California 94107

A Phase 2 clinical study for patients with Acute Liver Failure or Acute Liver Injury

Santa Cruz California 95065

Patients are needed to participate in a clinical research study of Legalon SIL (Silibinin) to evaluate Amatoxin Poisoning, Amanita Poisoning, Mushroom Poisoning or Liver Failure

Colorado

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Georgia

Atlanta Georgia 30322

A Phase 2 clinical study for patients with Acute Liver Failure or Acute Liver Injury

Atlanta Georgia 30309

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Illinois

Chicago Illinois 60611

A Phase 2 clinical study for patients with Acute Liver Failure or Acute Liver Injury

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating 13C-methacetin for the treatment of Acute Liver Failure

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Chicago Illinois 60611

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Kansas

Kansas City Kansas 66160

A Phase 2 clinical study for patients with Acute Liver Failure or Acute Liver Injury

Louisiana

New Orleans Louisiana 70112

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Michigan

Ann Arbor Michigan 48109

A Phase 2 clinical study for patients with Acute Liver Failure or Acute Liver Injury

Missouri

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

New Jersey

Somerset New Jersey 08873

Patients are needed to participate in a clinical research study of Legalon SIL (Silibinin) to evaluate Amatoxin Poisoning, Amanita Poisoning, Mushroom Poisoning or Liver Failure

New York

New York New York 10016

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Ohio

Columbus Ohio 43210

A Phase 2 clinical study for patients with Acute Liver Failure or Acute Liver Injury

Columbus Ohio 43210

Patients are needed to participate in a clinical research study evaluating 13C-methacetin for the treatment of Acute Liver Failure

South Carolina

Charleston South Carolina 29425

A Phase 2 clinical study for patients with Acute Liver Failure or Acute Liver Injury

Tennessee

Nashville Tennessee 37212-1610

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Texas

Dallas Texas 75390

A Phase 2 clinical study for patients with Acute Liver Failure or Acute Liver Injury

Dallas Texas 75390-8887

Patients are needed to participate in a clinical research study evaluating 13C-methacetin for the treatment of Acute Liver Failure

Dallas Texas 75203

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Houston Texas 77030

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Virginia

Richmond Virginia 23298

A Phase 2 clinical study for patients with Acute Liver Failure or Acute Liver Injury

Richmond Virginia 23298

Patients are needed to participate in a clinical research study evaluating 13C-methacetin for the treatment of Acute Liver Failure

Richmond Virginia 23249

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Richmond Virginia 23298

Patients are needed to participate in a clinical research study of Placebo and Rifaximin to evaluate Hepatic Encephalopathy

Washington

Seattle Washington 98195

A Phase 2 clinical study for patients with Acute Liver Failure or Acute Liver Injury

Belgium

Brussels 1070

A clinical trial seeking patients for a research study for the treatment of Acute-On-Chronic Liver Failure

Leuven 3000

A clinical trial seeking patients for a research study for the treatment of Acute-On-Chronic Liver Failure

Korea, Republic of

Seoul 90248

A clinical trial seeking patients for a research study for the treatment of Liver Failure

United Kingdom

London Hampstead NW3 2QG

A clinical trial to evaluate treatments using DIALIVE Liver Dialysis Device for patients with Acute on Chronic Liver Failure

Vietnam

Hue

A clinical trial to evaluate treatments using TONKA and LEGALON for patients with Liver Function Failure